Valuation: CeriBell, Inc.

Market Cap 677M 594M 553M 509M 953M 64.63B 970M 6.56B 2.57B 32.05B 2.54B 2.48B 111B P/E 2026 *
-10.5x
P/E 2027 * -15.5x
Enterprise Value 663M 582M 542M 499M 935M 63.37B 951M 6.43B 2.52B 31.43B 2.49B 2.44B 109B EV / Sales 2026 *
5.82x
EV / Sales 2027 * 4.47x
Free-Float
87.21%
Yield 2026 *
-
Yield 2027 * -
1 day+0.25%
1 week+6.84%
Current month-7.61%
1 month-9.97%
3 months-6.65%
6 months-12.04%
Current year-18.06%
1 week 15.96
Extreme 15.96
18.73
1 month 15.96
Extreme 15.96
20.46
Current year 15.84
Extreme 15.84
24.33
1 year 10.85
Extreme 10.85
24.33
3 years 10.01
Extreme 10.01
32.75
5 years 10.01
Extreme 10.01
32.75
10 years 10.01
Extreme 10.01
32.75
Manager TitleAgeSince
Chief Executive Officer 46 2015-09-30
Director of Finance/CFO 44 2020-03-31
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 46 2014-08-28
Chairman 57 2014-08-28
Director/Board Member 64 2021-03-31
Date Insider Type Main position Quantity % Market Cap.
7/7/26 Sell

Founder

-89,000 0.2346%
6/30/26 Sell

Director

-2,207 0.0058%
6/26/26
TPG Group Holdings (SBS) Advisors, Inc.
SellCompany -202,368 0.5334%
Change 5-day change 1-year change 3-year change Capi.($)
+0.31%+6.84%+21.75% - 677M
+2.78%+13.12%-12.27%+14.21% 3.86B
-1.36%+12.61%+42.58% - 1.4B
-0.38%+1.95%-9.97%-2.06% 151M
-15.11%-15.02%+29.49%+23.23% 114M
Average -2.78%-0.68%+14.32%+11.79% 1.24B
Weighted average by Cap. +1.13%+6.07%+4.63%+13.86%

Financials

2026 *2027 *
Net sales 114M 100M 93.16M 85.69M 161M 10.89B 163M 1.11B 433M 5.4B 428M 419M 18.66B 146M 128M 119M 110M 206M 13.93B 209M 1.41B 554M 6.91B 548M 536M 23.88B
Net income -65.38M -57.38M -53.43M -49.15M -92.13M -6.25B -93.71M -634M -248M -3.1B -245M -240M -10.7B -44.3M -38.88M -36.2M -33.3M -62.42M -4.23B -63.49M -429M -168M -2.1B -166M -163M -7.25B
Net Debt -13.26M -11.64M -10.84M -9.97M -18.68M -1.27B -19M -129M -50.32M -628M -49.78M -48.7M -2.17B -24.76M -21.73M -20.24M -18.61M -34.89M -2.37B -35.49M -240M -93.98M -1.17B -92.97M -90.96M -4.05B
Logo CeriBell, Inc.
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its hardware is composed of disposable, flexible headbands and head caps (Wearables) and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals. EEG data captured by the recorder are interpreted by its proprietary AI-powered seizure detection algorithms, which monitor the patient’s EEG signal and support the clinician’s real-time assessment of seizure activity.
Employees
327
Date Price Change Volume
26-07-29 US$17.85 +0.11% 97,635
26-07-28 US$17.83 -1.65% 311,417
26-07-27 US$18.13 +7.21% 442,387
26-07-24 US$16.91 +3.87% 363,473
26-07-23 US$16.28 -3.21% 406,282
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
17.83USD
Average target price
26.86USD
Spread / Average Target
+50.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CBLL Stock